A Reverse phase HPLC method Development and Validation of 2,4,6 Trifluro Benzoic acid and its impurities: A Key Raw Material Used In Preparation of Anti Migraine Drug Lasmiditan Hemisuccinate
Reddy, M., Raghavendra, A., Kishore, &., Venkat Reddy, E., Yakaiah, D., Surya Varma, V., Karthikeyan, T., Kishore Kumar Reddy, A., Bhaskar, P. (2023). A Reverse phase HPLC method Development and Validation of 2,4,6 Trifluro Benzoic acid and its impurities: A Key Raw Material Used In Preparation of Anti Migraine Drug Lasmiditan Hemisuccinate. EKB Journal Management System, 66(10), 49-53. doi: 10.21608/ejchem.2023.155748.6738
M. Maheswar Reddy; A. Raghavendra;  B. Kishore; E. Venkat Reddy; D. Yakaiah; V.B. Surya Varma; T. Karthikeyan; A.N. Kishore Kumar Reddy; P. Vijay Bhaskar. "A Reverse phase HPLC method Development and Validation of 2,4,6 Trifluro Benzoic acid and its impurities: A Key Raw Material Used In Preparation of Anti Migraine Drug Lasmiditan Hemisuccinate". EKB Journal Management System, 66, 10, 2023, 49-53. doi: 10.21608/ejchem.2023.155748.6738
Reddy, M., Raghavendra, A., Kishore, &., Venkat Reddy, E., Yakaiah, D., Surya Varma, V., Karthikeyan, T., Kishore Kumar Reddy, A., Bhaskar, P. (2023). 'A Reverse phase HPLC method Development and Validation of 2,4,6 Trifluro Benzoic acid and its impurities: A Key Raw Material Used In Preparation of Anti Migraine Drug Lasmiditan Hemisuccinate', EKB Journal Management System, 66(10), pp. 49-53. doi: 10.21608/ejchem.2023.155748.6738
Reddy, M., Raghavendra, A., Kishore, &., Venkat Reddy, E., Yakaiah, D., Surya Varma, V., Karthikeyan, T., Kishore Kumar Reddy, A., Bhaskar, P. A Reverse phase HPLC method Development and Validation of 2,4,6 Trifluro Benzoic acid and its impurities: A Key Raw Material Used In Preparation of Anti Migraine Drug Lasmiditan Hemisuccinate. EKB Journal Management System, 2023; 66(10): 49-53. doi: 10.21608/ejchem.2023.155748.6738

A Reverse phase HPLC method Development and Validation of 2,4,6 Trifluro Benzoic acid and its impurities: A Key Raw Material Used In Preparation of Anti Migraine Drug Lasmiditan Hemisuccinate

Egyptian Journal of Chemistry
Volume 66, Issue 10, October 2023, Page 49-53  XML PDF (430.02 K)
Document Type: Original Article
DOI: 10.21608/ejchem.2023.155748.6738
View on SCiNiTO View on SCiNiTO
Authors
M. Maheswar Reddy; A. Raghavendra;  B. Kishore; E. Venkat Reddy; D. Yakaiah; V.B. Surya Varma; T. Karthikeyan; A.N. Kishore Kumar Reddy; P. Vijay Bhaskar email
R&D Center (API), Uquifa India Private Limited, CSIR-IICT, D-112, Discovery Building, Tarnaka, Hyderabad, Telangana, India -50007
Abstract
A novel gradient reverse phase liquid chromatographic (RP-HPLC) method is developed and validated for the determination of purity of 2,4,6 Trifluro benzoic acid (TBA) in presence of its related impurities. TBA is very important key raw material used in the process development of Active Pharmaceutical Ingredient (API), Lasmiditan Hemisuccinate. The impurities formed during the synthesis of TBA will diminishes the pharmacological quality of the Lasmiditan Hemisuccinate. Hence, the stringent control of TBA and its related impurities were significantly important to achieve the niche quality of Lasmiditan Hemisuccinate. This HPLC method developed by using Zorbax SB-Aq, 5 µm, 4.6 x 250 mm column with mobile phase containing a gradient mixture of solvent A and B. The buffer is 0.1% triethyl amine solution is solvent A and acetonitrile, methanol, water in the ratio of 700:200:100 v/v/v solvent mixture is solvent B. The eluted compounds monitored at 205 nm. This method validated as per International Conference on Harmonization (ICH) guidelines with respect to specificity, limit of detection, limit of quantitation, precision, linearity, accuracy and system suitability
Keywords
Keywords: 2; 4; 6 trifluro benzoic acid (TBA); Lasmiditan Hemisuccinate; HPLC-Development; Validation
Statistics
Article View: 295
PDF Download: 210